ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

STTK vs PBYI // NET PROFIT MARGIN

Shattuck Labs Inc. (NASDAQ) VS. Puma Biotechnology Inc (NASDAQ) • 15-METRIC TALLY: STTK 2 — PBYI 7
▲ NET PROFIT MARGIN LEADER: PBYI
net-margins
13.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STTK VS. PBYI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC STTK PBYI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 74.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 29.30% -64.30 PBYI /roic <GO>
EV/EBITDA & P/E Valuation — 13.8x — TIE /valuation <GO>
Free Cash Flow Yield -6.96% 7.67% -14.63 PBYI /fcf-yield <GO>
Operating Margin -60.00% 16.30% -76.30 PBYI /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% 13.60% -73.60 PBYI /net-margins <GO>
Revenue Growth (YoY) -65.00% -0.90% -64.10 PBYI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 0.20 +25.80 STTK /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 PBYI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.8 52.6 -8.80 PBYI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 16.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $558.0M $538.9M $19.1M STTK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR STTK REV PBYI REV STTK GROSS % PBYI GROSS % STTK FCF PBYI FCF
FY 2025 $1.0M $228.4M — 74.5% -$40.0M $41.7M
FY 2024 $5.7M $230.5M — 72.1% -$60.6M $38.9M
FY 2023 $1.7M $235.6M — — -$81.2M $27.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STTK // BETA —
PBYI // BETA —